Trials / Completed
CompletedNCT00386308
Efficacy and Safety Study of XP12B in Women With Menorrhagia
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study To Evaluate Efficacy and Safety of XP12B for the Treatment of Menorrhagia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 196 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic acid tablets | 3900 mg/Day |
| DRUG | Placebo tablets |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2006-10-11
- Last updated
- 2011-05-04
- Results posted
- 2010-02-22
Locations
52 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00386308. Inclusion in this directory is not an endorsement.